chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"I" had an adverse reaction to the booster vaccine. "I" had a stye and a UTI, no symptoms prior to thevaccine.; "I" had an adverse reaction to the booster vaccine. "I" had a stye and a UTI, no symptoms prior to thevaccine.; Dose number=3; This is a spontaneous report from a non-contactable reporter (consumer or other non-HCP). The reporter is the patient.   A 33-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 06Jan2022 at 11:00 (Lot number: FJ1611)at the age of 33 Year(s) as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Soy allergy" (unspecified if ongoing); "Allergy to nuts" (unspecified if ongoing), notes: Known allergies: Almonds and "Nickel sensitivity" (unspecified if ongoing), notes: Known allergies: Nickel. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EP6955, Anatomical Location: Right arm, Route of Administration: Unspecified, Time of Administration: 00:00), administration date: 21Mar2021, when the patient was 32 year(s) old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: ER8729 , Anatomical Location: Right arm, Route of Administration: Unspecified, Time of Administration: 00:00.), administration date: 11Apr2021, when the patient was 32 year(s) old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 06Jan2022 at 11:00, outcome "unknown", described as "dose number=3"; HORDEOLUM (non-serious), URINARY TRACT INFECTION (non-serious) all with onset 06Jan2022 at 19:00, outcome "recovering", and all described as ""I" had an adverse reaction to the booster vaccine. "I" had a stye and a UTI, no symptoms prior to the vaccine". Therapeutic measures were taken as a result of hordeolum and urinary tract infection.  Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received AZO for UTI and warm compress for eye as the treatment. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
fatigue; cough; sleeping around the clock; Headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date (Lot number was not reported) dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know the timing of dose two. The patient will go for a Sars-COV-2 Test. The patient was experiencing fatigue and cough on an unknown date. The patient stated that it seems like a horrible thing to go through to get a vaccine (as reported). The patient was having a hard time, was sleeping around the clock and has a headache on an unknown date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a 65 year old male, with no pertinent medical history, drug reactions or allergies who on 16-MAY-2007 was vaccinated with subcutaneously with 0.65 ml of Zostavax (Oka/Merck). There was no concomitant medication. On 28-JUN-2007, six weeks after receiving Zostavax (Oka/Merck) the patient developed Bell's Palsy. At the time of reporting the patient had not yet recovered. Unspecified medical attention was sought. There was no product quality complaint. The event of Bell's Palsy was considered as a other medically important medical event (OME). Additional information has been requested.
Pt developed petechiae around eyes, zygomatic arch, and nape shortly after administration of KINRIX and VARICELLA which were given today.  CBC w/diff WNL.
This spontaneous report as received from an administrator refers to a female non pregnant patient of unknown age. No pertinent medical history was reported. No drug reactions or allergies were reported. On 23-JUN-2014, the patient was vaccinated with a dose of PNEUMOVAX23 lot # J011799, exp 09-FEB-2015, subcutaneous injection (dose and dose number not reported). On an unspecified date, approximately in June 2014, the patient experienced skin surface infection below the injection site after receiving PNEUMOVAX23. The event was treated with cephalexin (unspecified dose and frequency). No lab diagnostics studies were performed. The outcome of event was reported as not recovered/not resolved. The patient sought medical attention by visiting the office on 25-JUN-2014. The relatedness between the event and PNEUMOVAX23 was not reported. Additional information has been requested.
This spontaneous report was received from a nurse via a company representative, referring to her son, a male patient (age 11 or 12 years). Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not reported. In 2016, the patient was vaccinated with his 1st dose of GARDASIL 9, intramuscularly, on his thigh (not specify if on his right or left leg) (lot # and expiration date were not provided) for prophylaxis. Other suspect therapies included meningococcal acyw conj vaccine (crm197) (MENVEO) which was administered on the same date and on the same leg to the patient. On an unknown date (reported as "after hours after the first dose of GARDASIL 9, the patient experienced a extremely swollen thigh, that was red and warm to touch (injection site reaction). Due to the events, the patient was seen in the local emergency room, nevertheless he was not admitted to the hospital. The reporter stated, that on an unknown date (reported as "weeks later"), the patient recovered form the injection site reaction. It was unknown which treatment was provided for the patient. The reporter was going to taker son for his 2nd dose of GARDASIL 9. Furthermore, no product quality issue was involved. The reporter did not provide for a causality between the adverse event and vaccination with GARDASIL 9. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA009737:
Information has been received from a consumer concerning her son who was vaccinated with measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Subsequently, her son passed away. Medical attention was sought. No product quality complaint involved. No further information is available.
Pt. in the observation lane was seeing black dots.  Paramedics assessed pt. once symptoms subsided paramedics released pt. to leave.
On 3/24/99, the pt developed bumps that resembled chickenpox from head to toe. The pt also developed a fever. Instructions were given to administer Tylenol and oatmeal baths.
Pt states that he started with his numbing sensation on his left side of his mouth on Feb. 24 2021, for the next 3 days he had the same symptoms. By the  third day he had the same sensation and now has traveled to his left side of his ear. Mouth started to droop on left side.
pt recvd 1st dose of Hep B vax & exp stinging pain @ the stie of the inject; pain persisted for a few seconds;
Chest and back pain, and then "limbs went numb".  Couldn't lift glass of water.  All limbs were weak and shaky.
booster; tested positive for COVID 19; tested positive for COVID 19; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 09Jan2022, outcome "unknown" and all described as "tested positive for COVID 19". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (09Jan2022) positive.  The patient tested positive for COVID 19 on 09Jan2022 and stated "My symptoms were cold like, relatively light, and 10 days later, gone. I credit this positive experience to the vaccine you developed. I have three shots thus far."  The lot number for bnt162b2 was not provided and will be requested during follow up.
"a bit of a fever after vaccines 8/13/2007 but cleared up and pt felt fine and ate well day before he died."  12/10/08 Death certificate states COD as SIDS.
The patient received an expired dose of ROTATEQ; Information has been received from the patient's father referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and with concomitant medication were not reported.      On an unknown date, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (1 dosage (DS)  X 10 tubes) (lot # N022174 with expiration date 16-MAR-2019) orally for prophylaxis. No product quality complaint (PQC) was involved.
SORENESS AT INJECTION SITE AND CHILLS Narrative:  SORENESS WAS SUCH THAT HE COULD NOT LIFT HIS ARMS
thoraco-lumbar inflammation; pain in the thoracic part of my back; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via an unspecified route of administration on Jan2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 in Dec2020 for covid-19. On an unspecified date, the patient started to experience some pain in the thoracic part of her back and the Doctor sent her an MRI showing that she have a thoraco-lumbar inflammation. Patient had never suffered from back pains before. Now patient have had to take injections and take oral medications. Patient heard that it could possibly be effects from the vaccine. Outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
DISCOMFORT (SICKNESS); fever; MASSIVE HEADACHE; fatigue; BODY ACHES; sore throat; chills; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included unknown.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On 17-MAR-2021, the subject experienced body aches. On 17-MAR-2021, the subject experienced sore throat. On 17-MAR-2021, the subject experienced chills. On 17-MAR-2021, the subject experienced fever. On 17-MAR-2021, the subject experienced massive headache. On 17-MAR-2021, the subject experienced fatigue. On 17-MAR-2021 10:15, the subject experienced discomfort (sickness). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the discomfort (sickness), chills, fever, massive headache, body aches, sore throat and fatigue was not reported. This report was non-serious.  As per follow up information, the following information were updated on 22th March, 2021. Due Diligence scheduled/Address updated for the primary reporter/ Event and Labeling checked./The Event "Headache" replaced as "massive headache" and coded
Information has been received from a registered nurse concerning an 18 year old female, who, on an unspecified date was vaccinated IM in the deltoid with a 0.5mL dose of GARDASIL. The patient was at the office for pelvic pain when she was vaccinated. Subsequently, post vaccination the patient experienced cramping in both legs and developed red spots over her face. The patient called the office. At the time of the report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
I had no symptoms immediately after vaccine except I tired out a little earlier than normal that day. I week later, I noticed the swelling and the pain. It started my entire foot, ankle, calf and knee. Foot was swollen but it did go down. I didn't think about it right off. I think it started in my right foot but it spread to my left foot and ankle, calf and knee. So both swelled and were painful for awhile. It just went down a little - the pain and swelling. It didn't go completely away but it was better. After the second vaccine, on April 7th,Lot # 038B21A -  I got really bad about seven or 8 days past the second vaccine (COVID vaccine). I swelled up severely. My knees were so bad you couldn't see them. The pads of the feet were so swollen. I had no wrinkles in my feet because they were so swollen. I was putting them up to elevate them as much as I could. I had a lot of problems with it. Both legs were severely swollen and painful. I was having a lot of pain with it. It scared me. I had a few pains in my chest, too. At the 10 days range after the second vaccine, the hands started swelling and the wrist and up my arm - the injection site didn't swell instead of my arm started swelling. The pain got so bad in my hands. I told me doctor. I couldn't walk around. The pain radiating was really bad - I tried icing and elevating and nothing was working. I even bought a pair of boots (medical support) to keep the blood circulating. As soon as I have the feet down even for an hour the pain and swelling just starts right back up. My hands are hurting, too. I started having numbing in the fingers, whole hand and into my wrist. The doctor put me on generic Lasix 20 twice a day  mg but for the last week or two weeks, we had to double it because my feet were so huge. My ankles are starting to discolor it's so bad. The doctor gave 10 mg Potassium tablets extended relief. He increased the Potassium when we increased the Lasix so that I take two Potassium - one in am and one in pm. It did not relieve the symptoms. It took the swelling down a hair but it's still real bad. I'm still having all the same issues - hands are numb and swollen now from talking on the phone.
11:30 shot given. 1pm left arm started to ache. A call to Dr. office-nurse said to ice it - that it could hurt for a few weeks. 10-19-16 patient could not lift arm and had no range of motion. Again told to ice it.
In the second dose she had a bad reaction to the vaccine; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (In the second dose she had a bad reaction to the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (In the second dose she had a bad reaction to the vaccine). At the time of the report, IMMUNISATION REACTION (In the second dose she had a bad reaction to the vaccine) outcome was unknown.            No concomitant product reported by reporter. No treatment medication reported by reporter.
Rash on Arm; Swollen Arm; poping sensation; Hot arm; Lump and blister on Arm; Red Arm; Fatigue; Achiness; Headache; sinus cogestion; This spontaneous case was reported by a consumer and describes the occurrence of SINUS CONGESTION (sinus cogestion), PERIPHERAL SWELLING (Swollen Arm), FORMICATION (poping sensation), RASH (Rash on Arm) and FEELING HOT (Hot arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced SINUS CONGESTION (sinus cogestion), FATIGUE (Fatigue), MYALGIA (Achiness) and HEADACHE (Headache). On 02-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen Arm), FORMICATION (poping sensation), FEELING HOT (Hot arm), BLISTER (Lump and blister on Arm) and ERYTHEMA (Red Arm). On 04-Apr-2021, the patient experienced RASH (Rash on Arm). At the time of the report, SINUS CONGESTION (sinus cogestion), PERIPHERAL SWELLING (Swollen Arm), FORMICATION (poping sensation), RASH (Rash on Arm), FEELING HOT (Hot arm), BLISTER (Lump and blister on Arm), ERYTHEMA (Red Arm), FATIGUE (Fatigue), MYALGIA (Achiness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information  included cortisone cream, Benadryl, and Neosporin ointment.
Acute DVT and acute occipital temporal infarction, symptoms - loss of peripheral vision in upper left quadrant
Information has been received from a licensed practical nurse concerning an elderly female patient who is a diabetic and has a history of mastectomy who on approximately 20-OCT-2005 "three weeks ago" was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #649914/0578P). "Within 24 hours of dosing" the patient experienced cellulitis. It was noted that if she would have waited a few more days before contacting the physician's office, would have required hospitalization. It was noted that she was treated with compresses, antibiotics and acetaminophen (Tylenol). Subsequently, all of the patients recovered. No product quality complaint was involved. Cellulitis was considered to be an other important medical event (OMIC). Additional information has been requested.
Information has been received from a pharmacist concerning a 60 year old female who on 27-APR-2012 was vaccinated with a dose of ZOSTAVAX (lot # 672609/1733AA, expiry date 04-FEB-2013), 0.65 mL, subcutaneously. On 28-APR-2012 the patient experienced cellulitis at the injection site (deltoid region). The patient sought unspecified medical attention. The patient put on cephalexin, 500 mg, 3 times daily for 7 days for the adverse effect. At the time of reporting, the patient's status was unknown. Follow up information has been received from the pharmacist concerning a 60 year old female patient who on 28-APR-2012 experienced swelling at injection site, redness and warm and was diagnosis with cellulitis. On 30-APR-2012, the patient saw doctor. The patient was given cephalexin, 500 mg, 3 times daily for 7 days. The patient required emergency room/doctor visit. At the time of reporting, the patient's outcome was unknown. Follow up information was received from a health care professional who stated that on 28-APR-2012 the patient with not known illness at time of vaccination developed small rash around the injection site and was diagnosed by physician with cellulitis. The patient prescribed cephalexin, 500 mg, 3 times daily for 7 days and in 2012 the symptoms resolved. The relatedness for cellulitis at the injection site (deltoid region) is unknown for ZOSTAVAX. Additional information is not expected.
Patient received Tdap vaccine, no immediate reaction. Patient was paying for vaccine about 15 minutes later, when he asked if dizziness is normal after this vaccine. Less than 30 seconds later, he lost consciousness and slumped down to the floor. I layed him on his side, and called for help on the floor and for 911 call to be placed. Less than 1 minute later, he regained consciousness. He slowly sat up and remained sitting while propped up for about 30 minutes. A sales floor attendant gave him a carbonated drink and cool towel. He asked for the 911 call to be cancelled and did not want any medical attention. The patient walked out of the store without assistance. I checked up on the patient the following morning; no further adverse symptoms.
Patient did fine the day of vaccination (2-23-21), but fell at 5:40am the next morning, and then fell again at 7:40am.  As a result of the falls was less responsive after that
feel bad; Initial information received on 31-Oct-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer via social media via Digital Media.   This case involves an (unknown age and gender) patient who experienced feel bad(feeling abnormal) while receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer batch number, expiry date not reported via unknown route in unknown administration site for prophylactic vaccination.   On an unknown date the patient experienced non-serious feel bad (feeling abnormal) (latency unknown) following the administration of INFLUENZA VACCINE.  It was reported" I took mine and started to feel bad. I shouldn't have taken it".   It is unknown if the patient experienced any additional symptoms/ events.   It is unknown if there were lab data/ results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome of the reported event was unknown.  There will be no information on the batch number for this case.
The patient was anxious about getting the flu shot. He was very tense while I was injecting. The mother and I tried comforting him by telling him that the vaccine would prevent the flu (which is go in March of 2017). The boy was still for the injection and then afterwards said it was bad. He stood up next to his mother so his father could sit down and get his vaccine. The boy was talking with his parents and me while I completed the father's vaccine and while the family was getting ready to leave. Then the child fainted and fell to the floor. His fall was broken because he banged into me before hitting the ground. His mother immediately went to the ground to try and rouse him and I went to call 911. The boy awoke after about 10-15 seconds. He continued to lie on the ground and nod in response to his mother asking if he was okay. The boy asked for water and wanted to sit up. The father went to get water and the mother assisted the boy into the chair. He was giving short answers to our questions and then had some water the father brought to him. The EMTs arrived and talked to the parents about possible vasovagal reaction. While the EMTs were speaking with the parents the boy vomited. The parents decided to let the ambulance take the patient to the hospital to have him examined by a physician.
Body aches Fever Chills Loss of appetite  Night sweats and fever went on for two weeks Currently still going on